Statin use and sepsis in patients with chronic kidney disease [4]

JAMA

Volumn 298, Issue 3, 2007, Pages 284-

  Chenaud, Catherine ^a   Merlani, Paolo ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; STATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CHOLESTEROL;

CHRONIC KIDNEY DISEASE; DIALYSIS; DRUG USE; HOSPITALIZATION; HUMAN; LABORATORY TEST; LETTER; MONOCYTE; PRIORITY JOURNAL; SEPSIS; T LYMPHOCYTE; BLOOD; CHRONIC KIDNEY FAILURE; NOTE; RENAL REPLACEMENT THERAPY; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; LIPID BLOOD LEVEL; MEDICARE;

APOLIPOPROTEIN A-I; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEPSIS;

EID: 34447506207     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.3.284-a     Document Type: Letter

References (6)

1. Gupta R, Plantinga LC, Fink NE, et al. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA. 2007;297(13):1455-1464.
2. Martin G, Duez H, Blanquart C, et al. Statin-induced inhibition of the Rhosignaling pathway activates PPARalpha and induces HDL apoA-I. J Clin Invest. 2001;107(11):1423-1432.
3. Ma J, Liao XL, Lou B, Wu MP. Role of apolipoprotein A-I in protecting against endotoxin toxicity. Acta Biochim Biophys Sin (Shanghai). 2004;36(6):419-424.
4. Hyka N, Dayer JM, Modoux C, et al. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contactmediated activation of monocytes by T lymphocytes. Blood. 2001;97(8):2381-2389.
5. Chenaud C, Merlani PG, Roux-Lombard P, et al. Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit Care Med. 2004;32(3):632-637.
6. Prata MM, Madeira C, Vicente O, Miguel MJ. Lipid profile in haemodialysis patients treated with recombinant human erythropoietin. Nephrol Dial Transplant. 1998;13(9):2345-2347.